Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Fluconazole Suspension vs Diflucan Under Fed Conditions
NCT04502277Phase 1Unknown
- Sponsor
- Sutphin Drugs
- Start
- Sep 2020
- Primary completion
- Dec 2020
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
Phase 1, randomised, open-label trial of fluconazole in candidiasis (2 arms), sponsored by Sutphin Drugs. Primary endpoint: Relative Bioavailability (AUC) at 72 hours. Status: unknown.
02
Drugs
fluconazole
03
Conditions
candidiasis
Beyond the preview
Go deeper on NCT04502277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04502277.